Associate Director
Moderna Therapeutics
Harleysville, Pennsylvania
Sanjeev is a seasoned scientist with 18 years of expertise in both regulated and discovery bioanalytical sciences, specifically focusing on biologics drug development. He currently leads the Bioanalytical and Molecular Assay group at Moderna. Dr. Sanjeev possesses extensive experience in pharmacokinetics/pharmacodynamics (PK/PD), anti-drug antibodies (ADA), critical reagent management, and biomarker analysis utilizing both liquid chromatography-mass spectrometry (LCMS) and immunoassay platforms.
An active member of the American Association of Pharmaceutical Scientists (AAPS) Leadership Committee, Dr. Sanjeev currently serves as the Secretary for the Bioanalytical Community group. His contributions to AAPS are manifold, including roles on the planning committees for the Land O’ Lakes (LOL) conference, National Biotechnology Conference (NBC), and PharmaSci360. Additionally, he has served as the Bioanalytical Lead for abstract screening, a member of the Career Development Committee, a participant in the non-liquid matrices committee, and the LCMS Lead for the Bio101 e-course.
Disclosure information not submitted.
Rapid Fires: Bioanalytical Lab Innovations 1
Monday, October 21, 2024
3:00 PM – 3:45 PM MT
Symposium: High Resolution Mass Spectrometry for Regulated Bioanalysis, Quo Vadis?
Tuesday, October 22, 2024
9:00 AM – 11:00 AM MT